Cargando…

Risk Variants in the Exomes of Children With Critical Illness

IMPORTANCE: Diagnostic genetic testing can lead to changes in management in the pediatric intensive care unit. Genetic risk in children with critical illness but nondiagnostic exome sequencing (ES) has not been explored. OBJECTIVE: To assess the association between loss-of-function (LOF) variants an...

Descripción completa

Detalles Bibliográficos
Autores principales: Motelow, Joshua E., Lippa, Natalie C., Hostyk, Joseph, Feldman, Evin, Nelligan, Matthew, Ren, Zhong, Alkelai, Anna, Milner, Joshua D., Gharavi, Ali G., Tang, Yingying, Goldstein, David B., Kernie, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617179/
https://www.ncbi.nlm.nih.gov/pubmed/36306130
http://dx.doi.org/10.1001/jamanetworkopen.2022.39122
_version_ 1784820784311566336
author Motelow, Joshua E.
Lippa, Natalie C.
Hostyk, Joseph
Feldman, Evin
Nelligan, Matthew
Ren, Zhong
Alkelai, Anna
Milner, Joshua D.
Gharavi, Ali G.
Tang, Yingying
Goldstein, David B.
Kernie, Steven G.
author_facet Motelow, Joshua E.
Lippa, Natalie C.
Hostyk, Joseph
Feldman, Evin
Nelligan, Matthew
Ren, Zhong
Alkelai, Anna
Milner, Joshua D.
Gharavi, Ali G.
Tang, Yingying
Goldstein, David B.
Kernie, Steven G.
author_sort Motelow, Joshua E.
collection PubMed
description IMPORTANCE: Diagnostic genetic testing can lead to changes in management in the pediatric intensive care unit. Genetic risk in children with critical illness but nondiagnostic exome sequencing (ES) has not been explored. OBJECTIVE: To assess the association between loss-of-function (LOF) variants and pediatric critical illness. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study examined ES first screened for causative variants among 267 children at the Morgan Stanley Children’s Hospital of NewYork-Presbyterian, of whom 22 were otherwise healthy with viral respiratory failure; 18 deceased children with bronchiolitis from the Office of the Chief Medical Examiner of New York City, of whom 14 were previously healthy; and 9990 controls from the Institute for Genomic Medicine at Columbia University Irving Medical Center. The ES data were generated between January 1, 2015, and December 31, 2020, and analyzed between January 1, 2017, and September 2, 2022. EXPOSURE: Critical illness. MAIN OUTCOMES AND MEASURES: Odds ratios and P values for genes and gene-sets enriched for rare LOF variants and the loss-of-function observed/expected upper bound fraction (LOEUF) score at which cases have a significant enrichment. RESULTS: This study included 285 children with critical illness (median [range] age, 4.1 [0-18.9] years; 148 [52%] male) and 9990 controls. A total of 228 children (80%) did not receive a genetic diagnosis. After quality control (QC), 231 children harbored excess rare LOF variants in genes with a LOEUF score of 0.680 or less (intolerant genes) (P = 1.0 × 10(−5)). After QC, 176 children without a diagnosis harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 1.8; 95% CI, 1.3-2.5). After QC, 25 children with viral respiratory failure harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 2.8; 95% CI, 1.1-6.6). A total of 114 undiagnosed children were enriched for de novo LOF variants in genes without a known disease association (observed, 14; expected, 6.8; enrichment, 2.05). CONCLUSIONS AND RELEVANCE: In this genetic association study, excess LOF variants were observed among critically ill children despite nondiagnostic ES. Variants lay in genes without a known disease association, suggesting future investigation may connect phenotypes to causative genes.
format Online
Article
Text
id pubmed-9617179
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-96171792022-11-29 Risk Variants in the Exomes of Children With Critical Illness Motelow, Joshua E. Lippa, Natalie C. Hostyk, Joseph Feldman, Evin Nelligan, Matthew Ren, Zhong Alkelai, Anna Milner, Joshua D. Gharavi, Ali G. Tang, Yingying Goldstein, David B. Kernie, Steven G. JAMA Netw Open Original Investigation IMPORTANCE: Diagnostic genetic testing can lead to changes in management in the pediatric intensive care unit. Genetic risk in children with critical illness but nondiagnostic exome sequencing (ES) has not been explored. OBJECTIVE: To assess the association between loss-of-function (LOF) variants and pediatric critical illness. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study examined ES first screened for causative variants among 267 children at the Morgan Stanley Children’s Hospital of NewYork-Presbyterian, of whom 22 were otherwise healthy with viral respiratory failure; 18 deceased children with bronchiolitis from the Office of the Chief Medical Examiner of New York City, of whom 14 were previously healthy; and 9990 controls from the Institute for Genomic Medicine at Columbia University Irving Medical Center. The ES data were generated between January 1, 2015, and December 31, 2020, and analyzed between January 1, 2017, and September 2, 2022. EXPOSURE: Critical illness. MAIN OUTCOMES AND MEASURES: Odds ratios and P values for genes and gene-sets enriched for rare LOF variants and the loss-of-function observed/expected upper bound fraction (LOEUF) score at which cases have a significant enrichment. RESULTS: This study included 285 children with critical illness (median [range] age, 4.1 [0-18.9] years; 148 [52%] male) and 9990 controls. A total of 228 children (80%) did not receive a genetic diagnosis. After quality control (QC), 231 children harbored excess rare LOF variants in genes with a LOEUF score of 0.680 or less (intolerant genes) (P = 1.0 × 10(−5)). After QC, 176 children without a diagnosis harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 1.8; 95% CI, 1.3-2.5). After QC, 25 children with viral respiratory failure harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 2.8; 95% CI, 1.1-6.6). A total of 114 undiagnosed children were enriched for de novo LOF variants in genes without a known disease association (observed, 14; expected, 6.8; enrichment, 2.05). CONCLUSIONS AND RELEVANCE: In this genetic association study, excess LOF variants were observed among critically ill children despite nondiagnostic ES. Variants lay in genes without a known disease association, suggesting future investigation may connect phenotypes to causative genes. American Medical Association 2022-10-28 /pmc/articles/PMC9617179/ /pubmed/36306130 http://dx.doi.org/10.1001/jamanetworkopen.2022.39122 Text en Copyright 2022 Motelow JE et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Motelow, Joshua E.
Lippa, Natalie C.
Hostyk, Joseph
Feldman, Evin
Nelligan, Matthew
Ren, Zhong
Alkelai, Anna
Milner, Joshua D.
Gharavi, Ali G.
Tang, Yingying
Goldstein, David B.
Kernie, Steven G.
Risk Variants in the Exomes of Children With Critical Illness
title Risk Variants in the Exomes of Children With Critical Illness
title_full Risk Variants in the Exomes of Children With Critical Illness
title_fullStr Risk Variants in the Exomes of Children With Critical Illness
title_full_unstemmed Risk Variants in the Exomes of Children With Critical Illness
title_short Risk Variants in the Exomes of Children With Critical Illness
title_sort risk variants in the exomes of children with critical illness
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617179/
https://www.ncbi.nlm.nih.gov/pubmed/36306130
http://dx.doi.org/10.1001/jamanetworkopen.2022.39122
work_keys_str_mv AT motelowjoshuae riskvariantsintheexomesofchildrenwithcriticalillness
AT lippanataliec riskvariantsintheexomesofchildrenwithcriticalillness
AT hostykjoseph riskvariantsintheexomesofchildrenwithcriticalillness
AT feldmanevin riskvariantsintheexomesofchildrenwithcriticalillness
AT nelliganmatthew riskvariantsintheexomesofchildrenwithcriticalillness
AT renzhong riskvariantsintheexomesofchildrenwithcriticalillness
AT alkelaianna riskvariantsintheexomesofchildrenwithcriticalillness
AT milnerjoshuad riskvariantsintheexomesofchildrenwithcriticalillness
AT gharavialig riskvariantsintheexomesofchildrenwithcriticalillness
AT tangyingying riskvariantsintheexomesofchildrenwithcriticalillness
AT goldsteindavidb riskvariantsintheexomesofchildrenwithcriticalillness
AT kerniesteveng riskvariantsintheexomesofchildrenwithcriticalillness